Inventor · disambiguated record
James E. Crowe, Jr.
Also filed as: CROWE JAMES · CROWE JAMES E · CROWE JAMES E JR · CROWE JAMES S
42 granted patents·31 pending applications·450 citations·filing 1990–2025
97Inventor score
Files withUNIV VANDERBILT41CROWE JAMES E4SCRIPPS RESEARCH INST4UNIV NORTH CAROLINA CHAPEL HILL3UNIV PENNSYLVANIA3
Top patents by PatentIndex Score
73 records- 0194US5922326AAttenuated respiratory syncytial virus vaccine compositionsUS HEALTH·Filed 1994·Granted Jul 13, 1999·109 cites·26 claims
- 0294US5762905AHuman neutralizing monoclonal antibodies to respiratory syncytial virusSCRIPPS RESEARCH INST·Filed 1993·Granted Jun 9, 1998·112 cites·29 claims
- 0393US7867497B2Monoclonal antibodies to respiratory syncytial virus and uses thereforUNIV VANDERBILT·Filed 2008·Granted Jan 11, 2011·23 cites·22 claims
- 0491US11345741B2Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)UNIV VANDERBILT·Filed 2021·Granted May 31, 2022·6 cites·26 claims
- 0591US8221759B2Neutralizing monoclonal antibodies to respiratory syncytial virusPILKINGTON GLENN R·Filed 2011·Granted Jul 17, 2012·19 cites·1 claims
- 0691US7488477B2Neutralizing monoclonal antibodies to respiratory syncytial virusINTRACEL RESOURCES LLC·Filed 2003·Granted Feb 10, 2009·37 cites·1 claims
- 0790US7364737B2Human neutralizing monoclonal antibodies to respiratory syncytial virusSCRIPPS RESEARCH INST·Filed 2004·Granted Apr 29, 2008·18 cites·16 claims
- 0890US6685942B1Human neutralizing monoclonal antibodies to respiratory syncytial virusSCRIPPS RESEARCH INST·Filed 1997·Granted Feb 3, 2004·64 cites·16 claims
- 0987US11021533B2Human Zika virus antibodies and methods of use thereforUNIV VANDERBILT·Filed 2017·Granted Jun 1, 2021·3 cites·20 claims
- 1085US12216120B2Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)UNIV VANDERBILT·Filed 2022·Granted Feb 4, 2025·1 cites·20 claims
- 1181US12226471B2Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C virusUNIV PENNSYLVANIA·Filed 2023·Granted Feb 18, 2025·0 cites·19 claims
- 1281US10479825B2Antibody-mediated neutralization of Marburg virusUNIV VANDERBILT·Filed 2016·Granted Nov 19, 2019·2 cites·24 claims
- 1381US8969622B2Dendritic molecular intracellular transporters and methods of making and using sameHARTH EVA M·Filed 2007·Granted Mar 3, 2015·3 cites·15 claims
- 1475US10117924B2Chimeric dengue virus E glycoproteins comprising mutant domain I and domain II hinge regionsUNIV NORTH CAROLINA CHAPEL HILL·Filed 2017·Granted Nov 6, 2018·2 cites·12 claims
- 1571US11692023B2Human zika virus antibodies and methods of use thereforUNIV VANDERBILT·Filed 2021·Granted Jul 4, 2023·0 cites·14 claims
- 1671US9821050B2Chimeric dengue virus E glycoproteins comprising mutant domain I and domain II hinge regionsUNIV NORTH CAROLINA CHAPEL HILL·Filed 2013·Granted Nov 21, 2017·2 cites·24 claims
- 1770US2025281593A1Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C virusUNIV PENNSYLVANIA·Filed 2025·Application pending·0 cites
- 1869US12037384B2Human monoclonal antibodies against yellow fever virus and uses thereforUNIV VANDERBILT·Filed 2022·Granted Jul 16, 2024·0 cites·27 claims
- 1968US11660332B2Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C virusUNIV PENNSYLVANIA·Filed 2018·Granted May 30, 2023·0 cites·8 claims
- 2068US11084869B2Antibody-mediated neutralization of Marburg virusUNIV VANDERBILT·Filed 2019·Granted Aug 10, 2021·0 cites·19 claims
- 2167US12188053B2Human monoclonal antibodies that neutralize pandemic GII.4 norovirusesUNIV VANDERBILT·Filed 2019·Granted Jan 7, 2025·0 cites·21 claims
- 2267US2009110684A1Neutralizing monoclonal antibodies to respiratory syncytial virusPILKINGTON GLENN R·Filed 2008·Application pending·0 cites
- 2366US11596679B2Hepatitis C virus gene sequences and methods of use thereforUNIV VANDERBILT·Filed 2018·Granted Mar 7, 2023·0 cites·19 claims
- 2466US2021324051A1Antibody-mediated neutralization of marburg virusUNIV VANDERBILT·Filed 2021·Application pending·0 cites
- 2564US11992520B2Human monoclonal antibodies to Staphylococcal aureus Isd proteins and uses thereofUNIV VANDERBILT·Filed 2019·Granted May 28, 2024·0 cites·18 claims
- 2663US2007269451A1Nucleic Acid VaccinationGLAXO GROUP LTD·Filed 2006·Application pending·0 cites
- 2762US11054423B2Antibody-mediated neutralization of ebolavirusesUNIV VANDERBILT·Filed 2020·Granted Jul 6, 2021·0 cites·12 claims
- 2862US5882651AAttenuated respiratory syncytial virus vaccine compositionsUS HEALTH·Filed 1995·Granted Mar 16, 1999·19 cites·16 claims
- 2962US2010040650A1Virus-Like paramyxovirus particles and vaccinesCROWE JR JAMES E·Filed 2009·Application pending·0 cites
- 3061US2023054956A1Human monoclonal antibodies that neutralize pandemic gii.4 norovirusesUNIV VANDERBILT·Filed 2022·Application pending·0 cites
- 3160US11939370B2Pan-ebola virus neutralizing human antibodies and methods of use thereforUNIV VANDERBILT·Filed 2019·Granted Mar 26, 2024·0 cites·15 claims
- 3259US12233127B2Human monoclonal antibodies to a new universal influenza A hemagglutinin head domain epitopeUNIV VANDERBILT·Filed 2019·Granted Feb 25, 2025·0 cites·16 claims
- 3359US2023365658A1REPAIRED THERAPEUTIC AND PROPHYLACTIC ANTIBODIES AGAINST SARS-CoV-2 VARIANTSL LIVERMORE NAT SECURITY LLC·Filed 2023·Application pending·0 cites
- 3459US2009162395A1Vaccine for rsv and mpvCROWE JR JAMES E·Filed 2008·Application pending·0 cites
- 3558US2024287160A1Antibody cocktail for treatment of ebolavirus infectionsUNIV VANDERBILT·Filed 2022·Application pending·0 cites
- 3657US11802146B2Polynucleotides encoding anti-chikungunya virus antibodiesMODERNATX INC·Filed 2019·Granted Oct 31, 2023·0 cites·23 claims
- 3757US11345743B2Antibody-mediated neutralization of chikungunya virusUNIV VANDERBILT·Filed 2019·Granted May 31, 2022·0 cites·35 claims
- 3856US2023181714A1Human monoclonal antibodies to venezuelan equine encephalitis virus and uses thereforUNIV VANDERBILT·Filed 2021·Application pending·0 cites
- 3955US2023063625A1Human antibodies to rift valley fever virusUNIV VANDERBILT·Filed 2021·Application pending·0 cites
- 4054US2024288426A1Human antibodies to crimean congo hemorrhagic fever virusUNIV VANDERBILT·Filed 2021·Application pending·0 cites
- 4153US12024555B2Human West Nile virus antibodies and methods of use thereforUNIV VANDERBILT·Filed 2019·Granted Jul 2, 2024·0 cites·20 claims
- 4253US10620204B2Antibody-mediated neutralization of Ebola virusesUNIV VANDERBILT·Filed 2016·Granted Apr 14, 2020·0 cites·11 claims
- 4353US2023065377A1Human antibodies to alphavirusesUNIV VANDERBILT·Filed 2020·Application pending·0 cites
- 4452US11957745B2Human Japanese Encephalitis Virus antibodies and methods of use thereforUNIV VANDERBILT·Filed 2019·Granted Apr 16, 2024·0 cites·20 claims
- 4552US8894997B2Monoclonal antibodies to influenza H1N1 virus uses thereofCROWE JAMES E·Filed 2010·Granted Nov 25, 2014·0 cites·6 claims
- 4652US2023078330A1Human anti-dengue antibodies and methods of use thereforUNIV VANDERBILT·Filed 2021·Application pending·0 cites
- 4752US2019255168A1Chimeric dengue virus e glycoproteins comprising mutant domain i and domain ii hinge regionsUNIV NORTH CAROLINA CHAPEL HILL·Filed 2018·Application pending·0 cites
- 4852US2025304659A1HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 1 (SARS-CoV-1)UNIV VANDERBILT·Filed 2025·Application pending·0 cites
- 4951US2025277015A1Human monoclonal antibodies to eastern equine encephalitis virus and uses thereforUNIV VANDERBILT·Filed 2025·Application pending·0 cites
- 5051US2023085393A1Human antibodies that neutralize zika virus and methods of use thereforUNIV VANDERBILT·Filed 2020·Application pending·0 cites
Showing the top 50 of 73 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →